Alnylam Pharmace. buy BMO Capital Markets
Start price
27.03.24
/
50%
€141.40
Target price
27.03.25
€216.31
Performance (%)
74.96%
End price
28.03.25
€247.40
Summary
This prediction ended on 28.03.25 with a price of €247.40. With a performance of 74.96% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. BMO_Capital_Markets has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 6.515% | 6.515% | -9.661% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by BMO_Capital_Markets for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€386.00
05.09.25
05.09.25
€402.93
05.09.26
05.09.26
-34.43%
09:30
09:30
Stopped prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€279.80
24.06.25
24.06.25
€310.57
24.06.26
24.06.26
-8.86%
25.06.26
25.06.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€210.70
24.06.24
24.06.24
€218.11
24.06.25
24.06.25
32.04%
25.06.25
25.06.25